Search results for: 'ce ad ngs'
- Related search terms
- NGS China
- ngs markets
- NGS market
- NGS Informatics Market Forecast to 2027
- NGS tertiary analysis
-
28 Mar 2022  |  Global  |  Market Research
Consumer Electronics Show (CES) Automotive and Transportation Highlights, 2022
Strategic Partnerships between OEMs and Tech Companies with AI-driven Technology Enable Future In-vehicle Experience
CES 2022 displayed trends that pave the way to innovations and technology adoption by automotive industry players worldwide. Frost & Sullivan segmented this report by automotive trends announced at CES 2022 under the following categories: a. Connected b. Autonomous c. Shared d. Electrification CES 2022 also saw exhibitors, tech companies,...
$2,450.00
Special Price $1,837.50 save 25 %
-
18 Nov 2022  |  Europe  |  Market Research
European Anaerobic Digestion (AD) and Biogas Production Growth Opportunities
The EU’s Green Taxonomy and the REPowerEU Plan have Put the Spotlight on Long-term Investments in the Sustainability of Renewable Natural Gas (RNG) Production through AD
Several European countries, including Germany, the United Kingdom, and Denmark, are at the forefront of leveraging the potential of biogas produced through the anaerobic digestion (AD) of energy crops, agricultural waste, organic waste, and sewage sludge. Subsidies and incentives are the key growth drivers. As part of its Net Zero by 2050 Strategy,...
$2,450.00
Special Price $1,837.50 save 25 %
-
29 Apr 2016  |  Global  |  Market Research
Global Life Science Instrumentation Market, Forecast to 2020
Innovative Next-generation Sequencing (NGS) Technology to Fuel Growth
The global life science instrumentation market recorded revenue of $4.05 billion in 2015; it is expected to grow at a Cumulative Annual Growth Rate (CAGR) of 7.6% from 2015 to 2020. Next-generation Sequencing (NGS) instruments has outpaced other research instruments due to reduced sequencing costs. Thermo Fisher Scientific, Agilent Technologies, an...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Dec 2023  |  Global  |  Technology Research
Advancements in Next-gen Sequencing and Genomic Analysis
NGS Platforms and Genomic Analysis to Ensure Transformational Growth of Precision Medicine
Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 May 2026  |  Global  |  Market Research
Global Molecular Diagnostic Market—Opportunities and Growth Indicators
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...
$2,450.00 -
17 Dec 2019  |  North America  |  Market Research
NA and EU Sensor Data Fusion Strategies for ADAS and AD Systems, Forecast to 2025
Strategies Influencing Key Design Elements of E/E Architecture and Sourcing AD Software to Achieve L3 and Above Autonomy
The evolution in autonomy and increase in the adoption of driver assistance systems have generated a need to sense and perceive the surrounding environment of a vehicle entirely and accurately. The fusion of forward-looking sensor data has given OEMs and Tier-I suppliers opportunities to offer multiple ADAS applications at low costs, while providin...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jan 2019  |  North America  |  Market Research
Global Regulations, Budgeting and Testing for Autonomous Driving (AD) Solutions, 2018
AD Technologies Set for Take-off; North America to Take the Lead Initially
Major automotive OEMs globally are now incorporating active safety and automated vehicle technologies in their future vehicle line-ups to enhance safety and driver comfort. To gauge the suitability of each technology, continuous testing and validation is a must. Based on supportive legislation, several regions across the globe have been identified ...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Jun 2014  |  Global  |  Market Research
Analysis of the Western European Next Generation Sequencing (NGS) Market
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2017  |  Europe  |  Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00
Special Price $2,250.00 save 25 %
-
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %